髂动脉分支装置保留盆腔灌注未减少EVAR后缺血性结肠炎
本研究基于ACS NSQIP数据库2012-2017年11,137例肾下腹主动脉瘤EVAR患者,比较标准EVAR、HAE及IBD的30天结局。结果发现三组缺血性结肠炎无显著差异;平均风险组HAE死亡率高于标准EVAR,IBD未优于HAE。
要点
- IBD保留盆腔灌注未降低EVAR后缺血性结肠炎发生率。
- 平均风险患者中HAE死亡率显著高于标准EVAR。
- IBD较HAE有死亡率降低趋势但未达统计学显著。
核心结论
- 缺血性结肠炎是EVAR罕见并发症,HAE不增加其风险,IBD不降低其发生率。
- 平均风险患者中HAE死亡率显著高于标准EVAR,IBD未改善死亡率。
研究设计与样本
- 回顾性队列研究,使用ACS NSQIP靶向EVAR模块2012-2017年数据。
- 共11,137例肾下EVAR,包括9263例EVAR、531例EVAR-HAE、1343例EVAR-IBD。
- 进一步分层为9016例平均风险组和2121例高风险组。
主要发现
- 全风险组和高风险组中,EVAR、EVAR-HAE、EVAR-IBD的30天结局(包括缺血性结肠炎)无显著差异。
临床怎么用
- HAE在平均风险患者中与更高死亡率相关,选择时需权衡。
- IBD保留盆腔灌注未显示降低缺血性结肠炎或改善死亡率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Ischemic colitis is a rare but devastating complication of endovascular repair of infrarenal abdominal aortic aneurysms. Although it is rare (0.9%) in standard endovascular aneurysm repair (EVAR), the incidence increases to 2% to 3% in EVAR with hypogastric artery embolization (HAE). This study investigated whether preservation of pelvic perfusion with iliac branch devices (IBDs) decreases the incidence of ischemic colitis. METHODS: We used the targeted EVAR module in the American College of Surgeons National Surgical Quality Improvement Program database to identify patients undergoing EVAR of infrarenal abdominal aortic aneurysm from 2012 to 2017. The cohort was further stratified into average-risk and high-risk groups. Average-risk patients were those who underwent elective repair for sizes of the aneurysms, whereas high-risk patients were repaired emergently for indications other than asymptomatic aneurysms. Within these groups, we examined the 30-day outcomes of standard EVARs, EVAR with HAE, and EVAR with IBDs. The primary outcome was the incidence of ischemic colitis. Secondary outcomes included mortality, major organ dysfunction, thromboembolism, length of stay, and return to the operating room. The χ2 test, Fisher exact test, Kruskal-Wallis test, and multivariate regression models were used for data analysis. RESULTS: There were 11,137 patients who had infrarenal EVAR identified. We designated this the all-risk cohort, which included 9263 EVAR, 531 EVAR-HAE, and 1343 EVAR-IBD procedures. These were further stratified into 9016 cases with average-risk patients and 2121 cases with high-risk patients. In the average-risk group, 7482 had EVAR, 411 had EVAR-HAE, and 1123 had EVAR-IBD. In the high-risk group, 1781 had EVAR, 120 had EVAR-HAE, and 220 had EVAR-IBD. There was no significant difference in 30-day outcomes (including ischemic colitis) between EVAR, EVAR-HAE, and EVAR-IBD in the all-risk and high-risk groups. In the average-risk cohort, EVAR-HAE was associated with a higher mortality rate than EVAR (2.2% vs 1.0%; adjusted odds ratio, 2.58; P = .01). Although EVAR-IBD was not superior to EVAR-HAE in 30-day mortality, major organ dysfunction, or ischemic colitis in this average-risk cohort, EVAR-IBD exhibited a trend toward lower mortality compared with EVAR-HAE in this cohort, but it was not statistically significant (1.0% vs 2.2%; adjusted odds ratio, 0.42; P = .07). CONCLUSIONS: Ischemic colitis is a rare complication of EVAR. HAE does not appear to increase the risk of ischemic colitis, and preservation of pelvic perfusion with IBDs does not decrease its incidence. Although HAE is associated with significantly higher mortality than standard EVAR in average-risk patients, the preservation of pelvic perfusion with IBDs does not appear to improve mortality over HAE.
引用
- Lu JJ, Glousman B, Macsata RA, et al. Preservation of pelvic perfusion with iliac branch devices does not decrease ischemic colitis compared with hypogastric embolization in endovascular abdominal aortic aneurysm repair. J Vasc Surg. 2019. PMID: 31471238. doi:10.1016/j.jvs.2019.05.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。